Many people with diabetes aren’t aware that the condition can affect eyesight. Here’s how to advocate for better care and treatments. “There is a huge lack of knowledge on how diabetes can affect your ...

The much-awaited phase III readout from Oculis Holding AG’s OCS-01 in diabetic macular edema (DME) fell short of expectations, delaying the possibility of a topical eye drop option for DME patients ...

When you have diabetes, it’s important to watch out for other serious health problems that can come along with it. Eye disease is a common condition that happens with diabetes. Blood sugar spikes can ...

Diabetic macular edema (DME) is a leading cause of vision loss in people with diabetes. It occurs when high blood sugar levels damage small blood vessels in the retina, the light-sensitive tissue at ...

Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary ...

Diabetic macular edema (DME) can happen when high blood sugar damages eye vessels and causes fovea swelling. Early changes are easy to miss, so it’s important to get a yearly dilated eye exam. Regular ...

Diabetes comes with its share of complications, one of which is diabetic macular edema (DME). Roughly 1 in 14 people with diabetes develop this eye disease that can lead to vision loss. Early ...

For people living with diabetes, vision complications require immediate attention. Diabetic macular edema (DME), a condition causing fluid buildup in the eye’s central retina, demands particular ...

When you have type 1 or type 2 diabetes, it can lead to even more health problems. Diabetic macular edema (DME) is an eye disease that happens to about 10% of people with diabetes. It can happen to ...

Please provide your email address to receive an email when new articles are posted on . “The visual loss associated with DME is due to the accumulation and exudation of extracellular fluid within the ...

– The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with DME treated with Vabysmo who identify as African American, Black, Hispanic and ...

Adverum Biotechnologies disclosed in late April that a patient treated with its experimental gene therapy for diabetic macular edema (DME) experienced an unexpected drop in eye pressure, inflammation, ...